Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader https://ift.tt/2GcUfgA
via IFTTT